Abstract
BackgroundCurrent treatment recommendations recommend accelerating therapy when rheumatoid arthritis (RA) patients (pts) reach moderate to severe disease activity.ObjectivesTo assess whether initiating biologics among pts with moderate RA results in better...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
